Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.4 USD | -0.27% |
|
-2.98% | -4.59% |
06-20 | Bionano Genomics Says Revvity to Commercialize VIA Software | MT |
06-20 | Bionano Genomics, Inc. Announces Software Marketing Agreement with Revvity, Inc. for Newborn Sequencing Research | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.59% | 12.91B | |
+5.25% | 212B | |
+10.22% | 188B | |
+30.76% | 157B | |
+33.62% | 114B | |
+3.46% | 64.01B | |
+1.51% | 48.83B | |
-3.56% | 39.3B | |
+1.95% | 35.97B | |
+7.67% | 27B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Wells Fargo Starts Revvity With Equalweight Rating, $95 Price Target